Follow-up of erlotinib related uveitis.
The authors report the follow-up of a 68-year-old lady with bilateral anterior uveitis secondary to erlotinib. Erlotinib was started and stopped after symptoms and signs suggestive of severe bilateral anterior uveitis were noted. The patient developed signs of a non-ST elevation myocardial infarction, 12 days after stopping the erlotinib, and recovered without major problems. The patient also reported intermittent low-grade fever since starting erlotinib which resolved after stopping this drug. No further symptoms of uveitis were noted up to 6 month follow-up. The patient reported improved well being, resolution of ocular symptoms and intermittent low-grade fever at last follow-up (6 months after stopping erlotinib).
Department of Ophthalmology, Countess of Chester, Chester, UK.
Indu
I
Kumar
Kashif
K
Ali
Muniba
M
Usman-Saeed
Muhammad Usman
MU
Saeed
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D003937:Diagnosis, Differential; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D014605:Uveitis / Q000139:chemically induced* / Q000175:diagnosis; D014792:Visual Acuity
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride